Biotech Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering August 7, 2026
Biotech Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website August 6, 2026
Biotech Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases August 6, 2026
Biotech Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update August 6, 2026
Biotech Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program August 5, 2026
Biotech Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X August 5, 2026
Biotech IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update August 4, 2026
Biotech SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies August 4, 2026
Search
Biotech
August 7, 2026
August 6, 2026
August 6, 2026
August 6, 2026
August 6, 2026
August 5, 2026
August 5, 2026
August 5, 2026
August 4, 2026
August 4, 2026
